A Sanger sequencing protocol for SARS-CoV-2 S-gene

被引：16
|
作者：
Daniels, Rodney S. [1 ]
Harvey, Ruth [1 ]
Ermetal, Burcu [1 ]
Xiang, Zheng [1 ]
Galiano, Monica [1 ]
Adams, Lorin [1 ]
McCauley, John W. [1 ]
机构：
[1] Worldwide Influenza Ctr, WHO Collaborating Ctr Reference & Res Influenza, Francis Crick Inst, London, England
来源：
INFLUENZA AND OTHER RESPIRATORY VIRUSES | 2021年 / 15卷 / 06期
基金：
英国惠康基金; 英国医学研究理事会;
关键词：
base-calling accuracy; Sanger sequencing; SARS-CoV-2; S-gene; variant detection; NEUTRALIZING ANTIBODY-ACTIVITY;
D O I：
10.1111/irv.12892
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We describe a Sanger sequencing protocol for SARS-CoV-2 S-gene the Spike (S)-glycoprotein product of which, composed of receptor-binding (S1) and membrane fusion (S2) segments, is the target of vaccines used to combat COVID-19. The protocol can be used in laboratories with basic Sanger sequencing capabilities and allows rapid "at source" screening for SARS-CoV-2 variants, notably those of concern. The protocol has been applied for surveillance, with clinical specimens collected in either nucleic acid preservation lysis-mix or virus transport medium, and research involving cultured viruses, and can yield data of public health importance in a timely manner.
引用
收藏
页码：707 / 710
页数：4
相关论文
共 50 条
  • [21] Comparative evaluation of the Thermo fisher TaqPath™ COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens
    Granato, Paul A.
    Kimball, Simon R.
    Alkins, Brenda R.
    Cross, Deirdre C.
    Unz, Melissa M.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [22] Rampant C-to-U deamination accounts for the intrinsically high mutation rate in SARS-CoV-2 spike gene
    Liu, Xueyan
    Liu, Xuan
    Zhou, Jie
    Dong, Yu
    Jiang, Wen
    Jiang, Wenqing
    RNA, 2022, 28 (07) : 917 - 926
  • [23] Comparative evaluation of the Thermo fisher TaqPath™ COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens
    Paul A. Granato
    Simon R. Kimball
    Brenda R. Alkins
    Deirdre C. Cross
    Melissa M. Unz
    BMC Infectious Diseases, 21
  • [24] Emergence and evolution of SARS-CoV-2 genetic variants during the Cuban epidemic
    Guzman, Maria G.
    Perez, Lissette
    Tejero, Yahisel
    Mederos, Dailyn
    Aguado, Mirtha E.
    Pintos, Yanet
    Valdes, Odalys
    Alvarez, Mayling
    Ponce de Leon, Liena de Regla
    Baldoquin, Waldemar
    Martinez, Yenisleidys
    Figueredo, Claudia
    Naranjo, Celine
    Nunes, Lirialys
    Almaguer, Yanaris Lopez
    Fernandez, Jose R. de Armas
    Miranda, Jose A. Portal
    Kouri, Vivian
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2022, 2 (04):
  • [25] Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
    Bian, Lianlian
    Liu, Jianyang
    Gao, Fan
    Gao, Qiushuang
    He, Qian
    Mao, Qunying
    Wu, Xing
    Xu, Miao
    Liang, Zhenglun
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [26] A systematic review of Vaccine Breakthrough Infections SARS-CoV-2 Delta Variant
    Zhang, Mengxin
    Liang, Ying
    Yu, Dongsheng
    Du, Bang
    Cheng, Weyland
    Li, Lifeng
    Yu, Zhidan
    Luo, Shuying
    Zhang, Yaodong
    Wang, Huanmin
    Zhang, Xianwei
    Zhang, Wancun
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (02): : 889 - 900
  • [27] SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
    Willett, Brian J.
    Grove, Joe
    MacLean, Oscar A.
    Wilkie, Craig
    De Lorenzo, Giuditta
    Furnon, Wilhelm
    Cantoni, Diego
    Scott, Sam
    Logan, Nicola
    Ashraf, Shirin
    Manali, Maria
    Szemiel, Agnieszka
    Cowton, Vanessa
    Vink, Elen
    Harvey, William T.
    Davis, Chris
    Asamaphan, Patawee
    Smollett, Katherine
    Tong, Lily
    Orton, Richard
    Hughes, Joseph
    Holland, Poppy
    Silva, Vanessa
    Pascall, David J.
    Puxty, Kathryn
    Filipe, Ana da Silva
    Yebra, Gonzalo
    Shaaban, Sharif
    Holden, Matthew T. G.
    Pinto, Rute Maria
    Gunson, Rory
    Templeton, Kate
    Murcia, Pablo R.
    Patel, Arvind H.
    Klenerman, Paul
    Dunachie, Susanna
    Haughney, John
    Robertson, David L.
    Palmarini, Massimo
    Ray, Surajit
    Thomson, Emma C.
    NATURE MICROBIOLOGY, 2022, 7 (08) : 1161 - +
  • [28] Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
    Park, Heedo
    Park, Mee Sook
    Seok, Jong Hyeon
    You, Jaehwan
    Kim, Jineui
    Kim, Jeonghun
    Park, Man-Seong
    JOURNAL OF MICROBIOLOGY, 2022, 60 (03) : 308 - 320
  • [29] The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
    Chavda, Vivek P.
    Bezbaruah, Rajashri
    Deka, Kangkan
    Nongrang, Lawandashisha
    Kalita, Tutumoni
    VACCINES, 2022, 10 (11)
  • [30] Implementation of an In-House Platform for Rapid Screening of SARS-CoV-2 Genome Variations
    Ashrafi, Farzane Zare
    Mohseni, Marzieh
    Beheshtian, Maryam
    Fattahi, Zohreh
    Ghodratpour, Fatemeh
    Keshavarzi, Fatemeh
    Behravan, Hanieh
    Kalhor, Marzieh
    Jalalvand, Khadijeh
    Azad, Maryam
    Koshki, Mahdieh
    Jafarpour, Ali
    Ghaziasadi, Azam
    Abdollahi, Alireza
    Kiani, Seyed Jalal
    Ataei-Pirkooh, Angila
    Azhar, Iman Rezaei
    Bokharaei-Salim, Farah
    Haghshenas, Mohammad Reza
    Babamahmoodi, Farhang
    Mokhames, Zakiye
    Soleimani, Alireza
    Ziaee, Masood
    Javanmard, Davod
    Ghafari, Shokouh
    Ezani, Akram
    Moghaddam, Alireza Ansari
    Shahraki-Sanavi, Fariba
    Shahri, Seyed Mohammad Hashemi
    Azaran, Azarakhsh
    Yousefi, Farid
    Moattari, Afagh
    Moghadami, Mohsen
    Fakhim, Hamed
    Ataei, Behrooz
    Nasri, Elahe
    Poortahmasebi, Vahdat
    Varshochi, Mojtaba
    Mojtahedi, Ali
    Jalilian, Farid
    Khazeni, Mohammad
    Moradi, Abdolvahab
    Tabarraei, Alijan
    Piroozmand, Ahmad
    Yahyapour, Yousef
    Bayani, Masoumeh
    Aboofazeli, Amir
    Ghafari, Parsa
    Keramat, Fariba
    Tavakoli, Mahsa
    ARCHIVES OF IRANIAN MEDICINE, 2023, 26 (02) : 69 - 75
12345